DC
AGN

Davenport & Co’s Allergan plc AGN Stock Holding History

Davenport & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,522
Closed -$255K – 771
2019
Q3 		$255K Hold
1,522
– – ﹤0.01% 596
2019
Q2 		$255K Sell
1,522
-199
-12% -$27.6K ﹤0.01% 600
2019
Q1 		$252K Sell
1,721
-213
-11% -$30.9K ﹤0.01% 581
2018
Q4 		$258K Sell
1,934
-358
-16% -$58.7K ﹤0.01% 542
2018
Q3 		$437K Buy
2,292
+10
+0.4% +$1.84K 0.01% 469
2018
Q2 		$380K Buy
2,282
+979
+75% +$157K ﹤0.01% 503
2018
Q1 		$219K Buy
1,303
+31
+2% +$5.2K ﹤0.01% 628
2017
Q4 		$208K Sell
1,272
-152,778
-99% -$27.4M ﹤0.01% 644
2017
Q3 		$31.6M Buy
154,050
+591
+0.4% +$137K 0.4% 98
2017
Q2 		$37.3M Buy
153,459
+152,231
+12,397% +$35.8M 0.49% 87
2017
Q1 		$258K Hold
1,228
– – ﹤0.01% 525
2016
Q4 		$257K Buy
+1,228
New +$254K ﹤0.01% 529
2016
Q1 		– Sell
-3,479
Closed -$1.09M – 619
2015
Q4 		$1.09M Sell
3,479
-217
-6% -$64.6K 0.02% 267
2015
Q3 		$1M Hold
3,696
– – 0.02% 280
2015
Q2 		$1.12M Sell
3,696
-1,500
-29% -$447K 0.02% 268
2015
Q1 		$1.55M Buy
5,196
+756
+17% +$216K 0.02% 246
2014
Q4 		$1.14M Sell
4,440
-100
-2% -$25K 0.02% 270
2014
Q3 		$1.1M Sell
4,540
-105
-2% -$23.5K 0.02% 266
2014
Q2 		$1.04M Sell
4,645
-200
-4% -$41.4K 0.02% 275
2014
Q1 		$997K Hold
4,845
– – 0.02% 269
2013
Q4 		$814K Hold
4,845
– – 0.02% 290
2013
Q3 		$698K Sell
4,845
-321
-6% -$42.8K 0.01% 295
2013
Q2 		$652K Buy
+5,166
New +$585K 0.01% 275

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Davenport & Co's AGN Position: Q4 2019 in Review

Davenport & Co sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 1,522 shares — an estimated $255K sold.

Davenport & Co first reported a position in AGN in Q2 2013 and held it in 23 quarters. The position peaked at $37.3M in Q2 2017. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Davenport & Co reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Davenport & Co sold 1,522 Allergan plc shares in Q4 2019, an estimated $255K.
  • Davenport & Co first reported a position in Allergan plc in Q2 2013 and held it in 23 quarters.
  • Davenport & Co's Allergan plc position peaked at $37.3M in Q2 2017.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Davenport & Co's 13F filing for Q4 2019, filed 22 Jan 2020.